TPC
WVE icon

Takeda Pharmaceutical Company’s Wave Life Sciences WVE Stock Holding History

Takeda Pharmaceutical Company’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,346,892
Closed -$11M – 12
2024
Q3 		$11M Hold
1,346,892
– – 29.1% 2
2024
Q2 		$6.72M Hold
1,346,892
– – 2.89% 4
2024
Q1 		$8.31M Hold
1,346,892
– – 2.88% 6
2023
Q4 		$7.57M Buy
+1,346,892
New +$7.2M 2.31% 6

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Takeda Pharmaceutical Company's WVE Position: Q4 2024 in Review

Takeda Pharmaceutical Company sold out of Wave Life Sciences (WVE) in Q4 2024, closing a stake of 1,346,892 shares — an estimated $11M sold.

Takeda Pharmaceutical Company first reported a position in WVE in Q4 2023 and held it in 4 quarters. The position peaked at $11M in Q3 2024. 183 funds tracked by Wall St. Rank hold WVE as of Q4 2024.

  • Takeda Pharmaceutical Company reported no remaining Wave Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Takeda Pharmaceutical Company sold 1,346,892 Wave Life Sciences shares in Q4 2024, an estimated $11M.
  • Takeda Pharmaceutical Company first reported a position in Wave Life Sciences in Q4 2023 and held it in 4 quarters.
  • Takeda Pharmaceutical Company's Wave Life Sciences position peaked at $11M in Q3 2024.
  • 183 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2024.

Based on Takeda Pharmaceutical Company's 13F filing for Q4 2024, filed 12 Feb 2025.